CYP-001: Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs) clinical trials

A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD

This study is looking at a new treatment called CYP-001 for a serious condition called high-risk acute Graft Versus Host Disease (GvHD) after a stem cell transplant. It compares CYP-001 plus standard treatment to standard treatment alone.